|
Market Closed -
London S.E.
11:35:13 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 530.00 GBX | 0.00% |
|
0.00% | -13.82% |
| 10-15 | 4basebio fundraise; Geo Exploration secures grants | AN |
| 10-15 | 4basebio Targets at Least GBP15 Million from Share Sale | MT |
Company Valuation: 4basebio PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 75.75 | 87.45 | 83.77 | 154.9 | 95.19 | 82.35 | - | - |
| Change | - | 15.45% | -4.21% | 84.96% | -38.57% | -13.48% | - | - |
| Enterprise Value (EV) 1 | 67.92 | 86.45 | 83.77 | 135.6 | 95.19 | 86.95 | 102.9 | 114.9 |
| Change | - | 27.28% | -3.1% | 61.81% | -29.78% | -8.65% | 18.3% | 11.69% |
| P/E | -23.7x | -16.9x | -11x | -12.9x | - | - | - | - |
| PBR | 6.48x | 12.3x | - | 6.02x | - | 9.19x | 4.32x | 6.35x |
| PEG | - | -0.3x | -0.2x | -0.2x | - | - | - | - |
| Capitalization / Revenue | 224x | 326x | - | 166x | 56.2x | 82.8x | 17x | 5.66x |
| EV / Revenue | 201x | 323x | - | 145x | 56.2x | 87.4x | 21.3x | 7.9x |
| EV / EBITDA | -21.2x | -16x | - | -12.2x | -5.89x | -5.4x | -7.93x | -16.6x |
| EV / EBIT | -19.3x | -14.8x | - | -11.3x | -5.5x | -4.98x | -7.22x | -13.9x |
| EV / FCF | -16x | - | - | -11x | - | -5.38x | -7.35x | -10.2x |
| FCF Yield | -6.26% | - | - | -9.08% | - | -18.6% | -13.6% | -9.82% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.26 | -0.42 | -0.62 | -0.94 | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.338 | 0.268 | - | 0.933 | 1.693 | 0.9946 | 4.839 | 14.55 |
| EBITDA 1 | -3.207 | -5.409 | - | -11.11 | -16.17 | -16.1 | -12.97 | -6.901 |
| EBIT 1 | -3.527 | -5.84 | - | -12.04 | -17.31 | -17.46 | -14.24 | -8.287 |
| Net income 1 | -3.235 | -5.15 | -7.665 | -12.33 | - | -18.2 | - | - |
| Net Debt 1 | -7.828 | -1.001 | - | -19.39 | - | 4.6 | 20.51 | 32.54 |
| Reference price 2 | 6.150 | 7.100 | 6.800 | 12.100 | 6.150 | 5.300 | 5.300 | 5.300 |
| Nbr of stocks (in thousands) | 12,317 | 12,317 | 12,319 | 12,805 | 15,477 | 15,539 | - | - |
| Announcement Date | 5/9/22 | 5/11/23 | 6/5/24 | 5/27/25 | 5/20/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 87.42x | -5.4x | - | 111M | |
| 18.32x | 6.97x | 13.35x | 1.63% | 69.4B | |
| 30.72x | 8.25x | 27.72x | 0.05% | 57.24B | |
| 39.18x | 6.93x | 20.69x | 0.83% | 57.62B | |
| 34.57x | 3.29x | 14.19x | -.--% | 43.65B | |
| 51.08x | 5.91x | 32.37x | -.--% | 44.03B | |
| -18.44x | 177.78x | -19.56x | -.--% | 38.08B | |
| 36.57x | 9x | 23.45x | 0.36% | 36.31B | |
| 44.16x | 7.87x | 26.34x | -.--% | 32.61B | |
| 29.41x | 6.22x | 16.14x | -.--% | 25.47B | |
| Average | 29.51x | 31.96x | 14.93x | 0.32% | 40.45B | |
| Weighted average by Cap. | 29.33x | 22.94x | 17.62x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4BB Stock
- Valuation 4basebio PLC
Select your edition
All financial news and data tailored to specific country editions
